Fatty acid supplement
Medium-chain triglyceride
Treatment of long-chain fatty acid disorders and glucose transporter type 1 deficiency syndrome
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AX Various alimentary tract and metabolism products
A16AX17 Triheptanoin
D11465 Triheptanoin (USAN)
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Triheptanoin
D11465 Triheptanoin (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11465
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11465
Other DBs
CAS:
620-67-7
PubChem:
384585441
KCF data
ATOM 30
1 C1b C 14.1400 -16.5900
2 C1c C 15.3524 -17.2900
3 O7a O 12.9276 -17.2900
4 C1b C 16.5479 -16.5996
5 O7a O 17.7353 -17.2851
6 O7a O 15.3525 -18.6898
7 C7a C 16.5481 -19.3802
8 C1b C 17.7352 -18.6948
9 O6a O 16.5482 -20.7897
10 C1b C 18.9266 -19.3828
11 C1b C 20.1159 -18.6961
12 C1b C 21.3062 -19.3834
13 C1b C 22.4961 -18.6964
14 C1a C 23.6861 -19.3836
15 C7a C 18.9265 -16.5971
16 C1b C 20.1160 -17.2838
17 O6a O 18.9265 -15.1903
18 C1b C 21.3061 -16.5965
19 C1b C 22.4962 -17.2835
20 C1b C 23.6860 -16.5963
21 C1b C 24.8762 -17.2834
22 C1a C 26.0660 -16.5962
23 C7a C 11.7321 -16.5996
24 C1b C 10.5447 -17.2851
25 O6a O 11.7320 -15.1903
26 C1b C 9.3535 -16.5971
27 C1b C 8.1640 -17.2838
28 C1b C 6.9739 -16.5965
29 C1b C 5.7838 -17.2835
30 C1a C 4.5940 -16.5963
BOND 29
1 1 2 1
2 1 3 1
3 2 4 1
4 4 5 1
5 2 6 1
6 6 7 1
7 7 8 1
8 7 9 2
9 8 10 1
10 10 11 1
11 11 12 1
12 12 13 1
13 13 14 1
14 5 15 1
15 15 16 1
16 15 17 2
17 16 18 1
18 18 19 1
19 19 20 1
20 20 21 1
21 21 22 1
22 3 23 1
23 23 24 1
24 23 25 2
25 24 26 1
26 26 27 1
27 27 28 1
28 28 29 1
29 29 30 1